BioCentury
ARTICLE | Clinical News

Talvesta talotrexin: Phase I/II started

November 6, 2006 8:00 AM UTC

HNAB began the Phase II portion of an ongoing open-label Phase I/II trial of Talvesta. The Phase II portion will focus on complete remission rates in relapsed or refractory ALL patients . Data from th...